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Abstract
The EFSA Panel on Food Additives and Nutrient Sources added to Food (ANS) provides a scientiﬁc
opinion on the safety of glucosylated steviol glycosides proposed for use as a new food additive in
different food categories. According to the applicant, glucosylated steviol glycosides preparations
consist of not less than 95% (on anhydrous basis) total steviol glycosides, made up of glucosylated
steviol glycosides of different molecular weights as well as any remaining steviol glycosides. The
applicant proposed that glucosylated steviol glycosides and parent steviol glycosides undergo a
common metabolic process in pathway following ingestion and suggested that data from steviol
glycosides can be used for read-across to glucosylated steviol glycosides. The limited evidence
provided in the application dossier did not demonstrate the complete hydrolysis of the glucosylated
steviol glycosides. No toxicological studies on glucosylated steviol glycoside preparations under
evaluation have been provided for its assessment. The Panel concluded that the submitted data are
insufﬁcient to assess the safety of the glucosylated steviol glycoside preparations to be used as a new
food additive.
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Summary
Following a request from the European Commission to the European Food Safety Authority (EFSA),
the Panel on Food Additives and Nutrient Sources added to Food (ANS) was asked to provide a
scientiﬁc opinion on the safety in use of glucosylated steviol glycosides as a food additive in different
food categories, in accordance with Regulation (EC) No 1331/2008 establishing a common
authorisation procedure for food additives, food enzymes and food ﬂavourings.
According to the applicant, glucosylated steviol glycosides preparations consist of not less than
95% (on anhydrous basis) total steviol glycosides, made up of glucosylated steviol glycosides of
different molecular weights as well as any remaining steviol glycosides. The Panel noted that within
the typical components of the glucosylated steviol glycosides and parent steviol glycosides some steviol
glycosides – e.g. rebaudioside N, rebaudioside O – are not included within the current steviol
glycosides listed for the food additive E 960.
The applicant proposed that glucosylated steviol glycosides and parent steviol glycosides undergo a
common metabolic process in pathway following ingestion. Thus, the applicant suggested that data
from steviol glycosides can be used for read-across to glucosylated steviol glycosides.
The limited evidence provided in the application dossier did not demonstrate the complete
hydrolysis of the glucosylated steviol glycosides under what the Panel considered extreme hydrolysis
conditions. No further information on hydrolysis under realistic conditions was provided.
The applicant provided the information on the GRAS Notice No 375 for ‘glycosylated enzyme
treated stevia’. Since the applicant was not able to provide the full data from the studies described in
the GRAS Notice No 375, the Panel could not consider the information for the current assessment.
No toxicological studies on glucosylated steviol glycoside preparations under evaluation have been
provided for its assessment.
Considering that the complete hydrolysis of the glucosylated steviol glycosides was not
demonstrated, toxicological data on steviol glycosides cannot be used in a read-across approach to
fully evaluate the safety of the glucosylated steviol glycoside preparations under evaluation. The
Panel noted that in such circumstances a Tier 1 evaluation according to the Guidance on food additives
is required with the material under evaluation.
The Panel further noted that the proposed glucosylated steviol glycosides preparations may contain
up to 20 glucose moieties per molecule of steviol glycoside. The proposed permitted level for this new
food additive is expressed on a steviol equivalent basis (as for the already authorised food additive
steviol glycosides (E 960)). The Panel therefore considered that this could lead to an additional
exposure to glucose from a sweetener which is proposed to have a technological function of replacing
sugars in food.
Therefore, the Panel concluded that the submitted data are insufﬁcient to assess the safety of the
glucosylated steviol glycoside preparations to be used as a new food additive.
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1. Introduction
The present scientiﬁc opinion deals with the evaluation of the safety of glucosylated steviol
glycosides proposed for use as a new food additive in different food categories.
1.1. Background and Terms of Reference as provided by the European
Commission
1.1.1. Background
The use of food additives is regulated under the European Parliament and Council Regulation (EC)
No 1333/2008 on food additives.1 Only food additives that are included in the Union list, in particular
in Annex II to that regulation, may be placed on the market and used in foods under the conditions of
use speciﬁed therein.
An application has been introduced for the authorisation of the use of Glucosylated steviol
glycosides as sweetener in several food categories. Glucosylated steviol glycosides are manufactured
by adding glucose units (between 1 to 20 additional units) to steviol glycosides extracted from the
leaves of Stevia rebaudiana. This is achieved using enzymes that transfer glucose units from a starch
source to the steviol glycosides, and results in the production of a mixture of glucosylated steviol
glycosides (~80 to 92%) and non-modiﬁed parent steviol glycosides (~5 to 15%).
The addition of glucose units to parent steviol glycosides improve the sensory characteristics of the
glycosides by reducing bitterness and astringency. Glucosylated steviol glycosides preparations are
approximately 167 times sweeter than sucrose.
1.1.2. Terms of Reference
In accordance with Article 29(1)(a) of Regulation (EC) No 178/20022, the European Commission
(EC) asks the European Food Safety Authority (EFSA) to perform a risk assessment and to provide a
scientiﬁc opinion on the safety in use of Glucosylated steviol glycosides as a food additive, in
accordance with Regulation (EC) No 1331/20083 establishing a common authorisation procedure for
food additives, food enzymes and food ﬂavourings.
1.1.3. Information on existing evaluations and authorisations
According to the applicant, a number of enzyme-modiﬁed steviol glycosides preparations are
Generally Recognised as Safe (GRAS) in the US for use as ﬂavouring agents and/or general purpose
sweetener in foods.
Glucosylated Stevia Leaf Extract (GRAS notice 662) has been notiﬁed as to be GRAS (FDA, 2016a,b).
An Expert Panel convened by PureCircle concluded that the available data demonstrated that
glucosylated steviol glycosides are subject to the same metabolic fate as steviol glycosides, and
therefore, the safety conclusions that have been drawn for steviol glycosides could be extended to
PureCircle’s Glucosylated Stevia Leaf Extract. This was the basis for the GRAS notiﬁcation.
According to the applicant, a-Glucosyltransferase treated stevia is described as a substance
composed mainly of a-glucosylsteviosides obtained from stevia extract which is approved by the
Japanese Minister of Health, Labour and Welfare (MHLW) as a food additive (Japan Food Chemical
Research Foundation, 2014).
The safety of steviol glycosides as a food additive was evaluated by EFSA in 2010 (EFSA ANS Panel,
2010). Following the EFSA assessment in 2015 (EFSA ANS Panel, 2015), rebaudioside M was included
in the speciﬁcations for the food additive steviol glycosides (E 960) according to the Commission
Regulation (EU) No 231/20124. The latest evaluation of steviol glycosides by the Joint FAO/WHO
Expert Committee on Food Additives (JECFA) took place in 2016 (JECFA, 2016).
1 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ L
354, 31.12.2008, p. 16–33.
2 Regulation (EC) No 178/2002 of the European Parliament and of the Council of 28 January 2002 laying down the general
principles and requirements of food law, establishing the European Food Safety Authority and laying down procedures in
matters of food safety. OJ L 31, 1.2.2002, p. 1–24.
3 Regulation (EC) No 1331/2008 of the European Parliament and of the Council of 16 December 2008 establishing a common
authorisation procedure for food additives, food enzymes and food ﬂavourings. OJ L 354, 31.12.2008, p. 1–6.
4 Commission Regulation (EU) No 231/2012 of 9 March 2012 laying down speciﬁcations for food additives listed in Annexes II
and III to Regulation (EC) No 1333/2008 of the European Parliament and of the Council. OJ L 83, 22.3.2012, p. 1–295.
Glucosylated steviol glycosides as a food additive
www.efsa.europa.eu/efsajournal 5 EFSA Journal 2018;16(2):5181
2. Data and methodologies
2.1. Data
The present evaluation is based on the data on glucosylated steviol glycosides in a newly submitted
dossier by the applicant (Documentation provided to EFSA n. 1) and additional information submitted
by the applicant during the assessment process in response to a following request by EFSA
(Documentation provided to EFSA n. 2).
2.2. Methodologies
The assessment was conducted in line with the principles described in the EFSA Guidance on
transparency in the scientiﬁc aspects of risk assessment (EFSA Scientiﬁc Committee, 2009) and
following the relevant existing Guidance from the EFSA Scientiﬁc Committee.
The current ‘Guidance for submission for food additive evaluations’ (EFSA ANS Panel, 2012) has
been followed by the ANS Panel for the evaluation of the application for authorisation of the new food
additive glucosylated steviol glycosides.
3. Assessment
3.1. Technical data
3.1.1. Identity of the substance
Glucosylated steviol glycosides preparations were described by the applicant as being a mixture of
glucosylated steviol glycosides, containing 1–20 additional glucose units bound to the parent steviol
glycoside (Figure 1).
The applicant stated that based on distribution analyses: the mono-, di- and tri-glucosylated are the
predominant forms of the glucosylated steviol glycosides. From analytical data provided within the
application dossier, it can be observed that the proportion of each glucosylated steviol glycoside
(mono-, di-, tri-, poly-glucosylated) in the commercial preparation depends on the composition of
steviol glycosides in the starting material (> 95%) consisting of either rebaudioside A, rebaudioside D
or a mixture of steviol glycosides.
Glucosylated steviol glycosides preparations consist of not less than 95% (on anhydrous basis) total
steviol glycosides, made up of glucosylated steviol glycosides of different molecular weights as well as
any remaining steviol glycosides.
The glucosylated fraction of the total steviol glycosides is between 80% and 92% and the parent
glycosides between 5% and 15%.
The parent steviol glycosides include rebaudioside N and rebaudioside O in addition to the steviol
glycosides comprised in the current EU speciﬁcations for steviol glycosides (E 960).
According to the applicant, glucosylated steviol glycosides preparations are white to off-white
powders that have a clean taste with a mild odour and are soluble in water. The Panel noted that the
solubility in water varies between the different glucosylated steviol glycosides. According to the
applicant, the glucosylation increased the solubility in comparison to the parent steviol glycoside.
Glucosylated steviol glycosides as a food additive
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3.1.2. Proposed speciﬁcations
The speciﬁcations for glucosylated steviol glycosides preparations as proposed by the applicant are
presented in Table 1 (Documentation provided to EFSA n.1).
The applicant has provided certiﬁcates of analysis of ﬁve non-consecutive, independent batches
(Documentation provided to EFSA n. 1).
The Panel noted that in the deﬁnition of glucosylated steviol glycosides the origin of glucose is not
speciﬁed. However, according to the description of the manufacturing process, glucose source is
liqueﬁed tapioca starch.
Figure 1: A representative structure of a glucosylated steviol glycoside
Table 1: Speciﬁcations for glucosylated steviol glycosides preparations as proposed by the applicant
(Documentation provided to EFSA n. 1)
GLUCOSYLATED STEVIOL GLYCOSIDES
Synonyms
Deﬁnition The product is obtained by extracting and purifying steviol glycosides
(E 960) from the dried leaves of Stevia rebaudiana Bertoni, then reacting
these steviol glycosides with glucotransferase enzymes in the presence of
glucose resulting in the addition of glucose moieties to the parent steviol
glycosides. These glucosylated steviol glycosides are puriﬁed by
employing adsorption and ion exchange chromatography, resulting in a
ﬁnal product comprising not less than 95% steviol glycosides,
determined as the sum of the glucosylated and parent steviol
glycosides.
Chemical name, molecular formula
and molecular weight
Separate table for the chemical information for some example
glucosylated steviol glycosides. Note: This list is not exhaustive.
Assay Not less than 95% of total steviol glycosides, comprised of glucosylated
and parent glycosides, on the dried basis.
Description White to off-white powder, approximately 100–200 times sweeter than
sucrose (at 5% sucrose equivalency).
Identiﬁcation
Solubility Soluble in water
pH Between 4.5 and 7.0 (1 in 100 solution)
Purity
Total ash Not more than 1%
Loss on drying Not more than 6% (105°C, 2 h)
Residual solvents Not more than 200 mg/kg methanol
Not more than 3,000 mg/kg ethanol
Arsenic Not more than 1 mg/kg
Lead Not more than 1 mg/kg
Glucosylated steviol glycosides as a food additive
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The Panel noted that according to information provided in the application dossier the glucosylated
fraction will be approximately 80–92% and this has not been deﬁned in the proposed speciﬁcations.
The Panel considered that the analytical data provided are sufﬁcient to demonstrate conformity
with the proposed speciﬁcations.
No information was provided by the applicant on particle size, shape and distribution.
The Panel noted that neither microbiological parameters have been included nor limits for
environmental contaminants as pesticides in the proposed speciﬁcations. The maximum levels
proposed in the speciﬁcations for the solvents (methanol and ethanol) are much higher than the
analytical data provided. Regarding toxic elements, only maximum limits are proposed for lead and
arsenic whilst cadmium and mercury were also reported in the analysis provided. The maximum limits
proposed for toxic elements are much higher compared to the values obtained in the ﬁve batches
analysed (< 0.005 mg/kg for As, Cd and Hg and < 0.054 mg/kg for Pb). The Panel noted that these
parameters should be added to the proposed speciﬁcations and that, based on the analytical results
provided by the applicant, lower levels of the maximum limits for the heavy metals present as impurity,
should be considered in the proposed speciﬁcations.
3.1.3. Manufacturing process
Glucosylated steviol glycosides preparations are prepared in two production stages.
In a ﬁrst stage, steviol glycosides are extracted from dried leaves of S. rebaudiana using hot water
(temperature of 50–60°C). The ﬁltrate so obtained is separated, treated with a ﬂocculant, ﬁltered
(plate-and-frame ﬁlter press) and deionised (ion-exchange resins). The extract is then submitted to a
series of puriﬁcation and concentration steps and ﬁnally spray-dried to yield a high-purity stevia extract
in powder form with a total steviol glycoside content of not less than 95%.
In a second separate stage, tapioca starch is liqueﬁed in a process, using natural cyclomaltodextrin
glucanotransferase (CGTase) and/or a-amylase, to generate glucose units. The natural CGTase is
derived from a non-genetically modiﬁed and a non-pathogenic strain of Bacillus stearothermophilus;
the natural a-amylase is derived from a non-genetically modiﬁed and non-pathogenic strain of
Bacillus licheniformis.
Next, the puriﬁed stevia extract powder, produced in the ﬁrst stage, is added to the liqueﬁed
tapioca starch together with an additional portion of CGTase. The mixture is incubated at 60°C for
48 h. In this process, puriﬁed steviol glycosides are enzymatically modiﬁed with glucotransferase
enzymes and the glucose moieties are conjugated to the parent steviol glycoside structure via a-(1–4)
linkages by the use of a CGTase. In the process, a mixture of glucosylated steviol glycosides containing
from 1 to 20 additional glucose units bound to the parent steviol glycoside is generated.
The enzymes are inactivated by heating 15 min at 100°C and removed by activated carbon. The
reaction mixture undergoes further a series of puriﬁcation and concentration steps. The reﬁned
solution is spray-dried and sifted to give the ﬁnal glucosylated steviol glycosides powder that consists
of not less than 95% total steviol glycosides and is made up of a mixture of glucosylated steviol
glycosides of different molecular weights as well as the remaining parent steviol glycosides.
The Panel noted that B. stearothermophilus and B. licheniformis are included in the list of qualiﬁed
presumption of safety (QPS)-recommended biological agents intentionally added to food or feed as
notiﬁed to EFSA 5 (EFSA BIOHAZ Panel, 2017). However, no statement on the absence of toxigenic
potential tested by a cytotoxicity assay and the general qualiﬁcation of the absence of acquired
antibiotic resistance were provided within the dossier.
3.1.4. Methods of analysis in food
No method of analysis of glucosylated steviol glycosides in foods was provided.
According to the applicant, total glucosylated steviol glycosides may be quantiﬁed by the assay for
a-Glucosyltransferase Treated Stevia published by the MHLW in the Japan’s Speciﬁcations and Standards
for Food Additives (MHLW, 2009). This method consists on a two-stage process involving the analysis of
parent steviol glycosides and glucose content separately. This is achieved by treating the glucosylated
steviol glycoside sample with glucoamylase to cleave the a-glucosyl residues from the parent steviol
glycosides. The concentration of D-glucose in the test solution is determined by the a-glucosyl residues
content in the formula. The a-glucosyl residues are quantiﬁed against a D-glucose standard and the
non-modiﬁed steviol glycoside content is measured according to JECFA method (JECFA, 2008). The sum
of the percentage of measured a-glucosyl residues and non-modiﬁed steviol glycosides represents the
total steviol glycoside content, comprised of the glucosylated and unreacted steviol glycosides.
Glucosylated steviol glycosides as a food additive
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3.1.5. Stability of the substance and reaction and fate in food
The submitted data demonstrated that the stability of glucosylated steviol glycoside preparations is
temperature-, time- and pH-dependent.
The applicant states that the stability of glucosylated steviol glycosides to temperature in a range
from 5 to 56°C and to pH from 2 to 8 over 8 weeks is equivalent to that of parent steviol glycosides.
With the highest losses of glucosylated steviol glycosides when stored at low pHs (2 and 3) and high
temperature (56°C). However, no information on the degradation products was submitted.
Information on the variation of the percentage of glucosylated steviol glycosides (e.g. mono-, di,
tri, etc.) was provided when the preparation at pH 3 (26,42 mg/mL) was stored during 8 weeks at
temperatures of 5, 25, 37 and 56°C and heated at 88°C for 30 s and at 138°C for 10 s
(Documentation provided to EFSA n. 2). The Panel noted that the relevance of this last study was very
limited to reach a conclusion due to the short heating period and the temperatures not being
representative of the temperatures reached during baking processes.
3.2. Proposed uses and use levels
According to the applicant, the glucosylated steviol glycoside preparations are proposed for use as
a high-intensity sweetener in the same manner as currently authorised for steviol glycosides (E 960) as
deﬁned in Annex II to Regulation (EC) No 1333/20085 (Documentation provided to EFSA n. 1).
3.3. Exposure estimate
The proposed permitted level for the new food additive glucosylated steviol glycosides are
expressed on a steviol equivalent basis as those of the already authorised food additive steviol
glycosides (E 960).
Because the proposed uses and use levels are the same as the already authorised food additive
steviol glycosides (E 960), the applicant did not provide an exposure estimate for the new proposed
food additive glucosylated steviol glycosides but made reference to the latest estimated exposure to E
960 (EFSA ANS Panel, 2015).
3.4. Biological and toxicological data
3.4.1. Absorption, distribution, metabolism and excretion
The microbial metabolism of two glucosylated steviol glycosides, a-monoglucosylated rebaudioside
A and a-monoglucosylated stevioside, was investigated in vitro using human faecal homogenates
(Koyama et al., 2003). The two glucosylated steviol glycosides were incubated with human faecal
homogenates for 24 h at 37°C under anaerobic conditions and metabolites generated were analysed
and identiﬁed by liquid chromatography–mass spectrometry (LC–MS). According to the authors, the
glucosylated steviol glycosides were completely metabolised to steviol after 24 h. Furthermore, the
authors also reported that a mixture of enzymatically modiﬁed stevia containing the primary
components a-glucosylated rebaudioside A, a-glucosylated stevioside, a-glucosylated rebaudioside C
and a-glucosylated dulcoside A was hydrolysed to steviol following a 24-h in vitro incubation with
human faecal homogenates. The metabolic pathway proposed for a-glucosylated steviol glycosides
starts with a-deglucosylation to the parent steviol glycoside, followed by hydrolysis to steviol, similar to
that established for parent steviol glycosides. The Panel noted that there were no intermediate
incubation times to provide information on the rate of degradation and that a considerable proportion
(20%) of enzymatically modiﬁed stevia remained intact or partially degraded after 24 h incubation with
faecal homogenates.
The applicant provided the publicly available information on the GRAS Notice No 375 for
‘glycosylated enzyme treated stevia’ describing two in vitro studies on the gastrointestinal degradation
(FDA, 2016b). Since the applicant was not able to provide information on the characterisation of the
test material in those studies to extrapolate the results to glucosylated steviol glycoside preparations
under evaluation (Documentation provided to EFSA n.2), the Panel could not consider the information
for the current assessment.
5 Regulation (EC) No 1333/2008 of the European Parliament and of the Council of 16 December 2008 on food additives. OJ L
354, 31.12.2008, p. 16–33.
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3.4.2. Short-term and subchronic toxicity
The applicant provided the publicly available information on the GRAS Notice No 375 for
‘glycosylated enzyme treated stevia’ describing a 13-week study in rats (FDA, 2016b). Since the
applicant was not able to provide the full data from this study including the characterisation of the test
material (Documentation provided to EFSA n. 2), the Panel could not consider the information for the
current assessment.
3.4.3. Genotoxicity
The applicant referred to the lack of in vitro and in vivo genotoxic activity reported in the GRAS
Notice No 375 for ‘glycosylated enzyme treated stevia’ (FDA, 2016b). Since the applicant was not able
to provide the full data from these studies including the characterisation of the test material
(Documentation provided to EFSA n. 2), the Panel could not consider the information for the current
assessment.
3.5. Discussion
The current assessment by the Panel is based on the information submitted in the application
dossier (Documentation provided to EFSA n. 1) and the additional information provided by the
applicant following a request by EFSA (Documentation provided to EFSA n. 2).
According to the applicant, glucosylated steviol glycosides preparations consist of not less than
95% (on anhydrous basis) total steviol glycosides, made up of glucosylated steviol glycosides of
different molecular weights as well as any remaining steviol glycosides. The Panel noted that within
the typical components of the glucosylated steviol glycosides and parent steviol glycosides some steviol
glycosides – e.g. rebaudioside N, rebaudioside O – are not included in the current steviol glycosides
listed for the food additive E 960.
The applicant proposed that glucosylated steviol glycosides and parent steviol glycosides undergo a
common metabolic process in pathway following ingestion. Thus, the applicant suggested that data
from steviol glycosides can be used for read-across to glucosylated steviol glycosides.
However, the evidence provided in the application dossier based on the study by Koyama et al.
(2003) did not demonstrate complete hydrolysis of the glucosylated steviol glycosides under what the
Panel considered extreme hydrolysis conditions. No further information on hydrolysis under realistic
conditions was provided.
The applicant provided the information on the GRAS Notice No 375 for ‘glycosylated enzyme
treated stevia’ (FDA, 2016b). Since the applicant was not able to provide the full data from the studies
described in the GRAS Notice No 375, the Panel could not consider the information for the current
assessment.
No toxicological studies on glucosylated steviol glycoside preparations under evaluation have been
provided for its assessment.
Considering that the complete hydrolysis of the glucosylated steviol glycosides was not
demonstrated, toxicological data on steviol glycosides cannot be used in a read-across approach to
fully evaluate the safety of the glucosylated steviol glycoside preparations under evaluation.
The Panel noted that in such circumstances a Tier 1 evaluation according to the Guidance on food
additives (EFSA ANS Panel, 2012) is required with the material under evaluation.
The Panel further noted that the proposed glucosylated steviol glycosides preparations may contain
up to 20 glucose moieties per molecule of steviol glycoside. The proposed permitted level for this new
food additive is expressed on a steviol equivalent basis (as for the already authorised food additive
steviol glycosides (E 960)). The Panel therefore considered that this could lead to an additional
exposure to glucose from a sweetener which is proposed to have a technological function of replacing
sugars in food.
4. Conclusions
The Panel concluded that the submitted data are insufﬁcient to assess the safety of the
glucosylated steviol glycoside preparations to be used as a new food additive.
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Documentation provided to EFSA
1) Dossier ‘Application for authorisation of glucosylated steviol glycosides as a food additive in
the European Union pursuant to Regulation (EC) No 1333/2008 of the European Parliament
and the Council of 16 December 2008 on food additive’. Submission on 17 March 2017.
Missing information submitted on 12 May 2017.
2) Additional information. 22 August 2017. Submitted by PureCircle in response to a request from EFSA.
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ANS EFSA Panel on Food Additives and Nutrient Sources added to Food
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CAS Chemical Abstracts Service
CGTase cyclomaltodextrin glucanotransferase
FDA Food and Drug Administration
GRAS Generally Recognized as Safe
JECFA Joint FAO/WHO Expert Committee on Food Additives
LC–MS liquid chromatography–mass spectrometry
MHLW Minister of Health, Labour and Welfare
WHO World Health Organization
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